Flunisolide for Asthma: Benefits, Usage, and Precautions

Overview:

What is Flunisolide? Flunisolide is an inhaled corticosteroid approved by the FDA (Food and Drug Administration). It is usually prescribed for the long-term treatment of asthma. Flunisolide works in both adults and children aged six years and above. It reduces inflammation and swelling in the airways. It also stops asthma symptoms like wheezing, coughing, chest tightness, and shortness of breath. Flunisolide is not taken as a rescue medication for the relief of acute asthma.

Drug Group:

It is categorized as corticosteroids (synthetic glucocorticoids). Flunisolide is an essential drug therapy for long-term asthma control. It gives patients better control over their respiratory system and a better quality of life.

Flunisolide Dosage Guidelines

Dosage:

Flunisolide is an inhalation aerosol in a pressurized metered dose inhaler with a built-in spacer. It delivers 60 or 120-metered 80-microgram doses.

1. In Adults: Flunisolide dosage for adults and adolescents aged 12 years and older:

   1. Recommended Starting Dose: 160 mcg twice daily.

   2. Highest Recommended Dose: 320 mg twice daily.

2. Children from Age Six to Eleven Years: The Flunisolide dosage for children is:

1. 1. Recommended Starting Dose: 80 mcg twice daily.

   2. Highest Recommended Dose: 160 mcg twice daily.

Administration:

Flunisolide inhalation aerosol is advised to be administered using the oral inhaled route. It is used in asthmatic patients aged six years and older. This product contains a built-in spacer.

Considerations for Administration:

The applicable handling and disposal procedures should be followed. It has to be orally inhaled in asthmatic patients. It should be administered in pediatric patients under adult supervision. In an emergency, the physician should be contacted, or the patient should be rushed to the emergency room in severe cases.

For Patients:

How Does Flunisolide Work?

Flunisolide is a corticosteroid. It can be used as a nasal spray to reduce nasal inflammation caused by allergies. It also works in the lungs to control asthma. Its anti-inflammatory action involves releasing lipocortin, inhibiting arachidonic acid, and controlling leukotriene and prostaglandin production. Flunisolide for asthma helps relieve symptoms and control episodes. While the exact mechanism of corticosteroids is unknown, it reduces airway inflammation. Flunisolide targets inflammatory cells and mediators, such as mast cells, eosinophils, histamine, and eicosanoids, effectively managing asthma.

How Effective Is Flunisolide?

Flunisolide is highly effective in reducing wheezing and runny nose-like symptoms. It is also effective in controlling nasal rhinitis symptoms. It reduces the inflammation in the nose, making the patient breathe easier.

What Are the Benefits/Clinical Uses of the Drug?

Flunisolide offers overall respiratory health management through several important benefits:

Key Clinical Benefits:

1. Asthma Symptom Control:

   1. Helps you have fewer asthma attacks.

   2. It makes any attacks you have less intense.

   3. Helps stop sudden breathing problems before they start.

   4. You're less likely to need an ER or urgent care trip.

2. Airway Management:

   1. Helps calm down swelling in your airways.

   2. Cuts down on the amount of mucus your lungs make.

   3. Helps your lungs work better overall.

3. Preventive Treatment:

   1. It works as a preventive medication, helping to stop symptoms before they start.

   2. It means you won’t rely on your rescue inhaler as much.

   3. Flunisolide offers protection to patients against the exacerbation of asthma.

4. Quality of Life Improvements:

   1. It helps improve the ability to perform everyday activities.

   2. It reduces nighttime breathing issues.

   3. It also supports respiratory performance.

5. Long-Term Health Management:

   1. Prevents possible lung injury.

   2. Decreases the risk of severe asthma complications.

   3. Ensures maximum lung function.

6. Individual Patient Benefits:

   1. Works well for children (6 years and older).

   2. Assists adults with chronic respiratory disease.

   3. Beneficial for athletes with exercise-induced asthma.

   4. Useful during high-allergen periods.

7. Therapeutic Benefits:

   1. Quick action.

   2. Low systemic side effects.

   3. Easy inhalation method.

   4. Specific respiratory treatment.

What Side Effects Can Flunisolide Medication Cause?

Flunisolide medication is used for the treatment of respiratory disorders. But, the chances of Flunisolide side effects occurring are still possible.

Here are a few of them mentioned in the following:

• Patches are painful in the mouth and the throat.

• Headaches.

• Stuffy nose.

• Stuffy throat.

• Swelling of the nose, sinuses, and throat.

• Nose bleeds and cough.

• Painful urination.

Some side effects can be severe, such as:

• Rash.

• Hives.

• Itching.

• The tongue, face, throat, and lips are swelling.

• Difficulty breathing and swallowing.

• Chest tightness and pain.

• Vision problems.

• Fever, body aches, and chills.

• Flunisolide inhalation can cause slow growth in children. The child's physician will carefully observe the child's growth using Flunisolide inhalation. Talk to the child's physician about the risks of giving this medication.

• Rarely, people who use Flunisolide inhalation for a long time may develop glaucoma or cataracts. Talk to the physician about the risks of using Flunisolide inhalation and how often the patient should examine their eyes during treatment.

• Flunisolide inhalation may increase the risk of developing osteoporosis. Talk to the physician about the risks of using this medication.

What Are the Things to Inform the Doctor Before Taking the Drug?

1. The physician and the pharmacist must be informed if the patient is known to be allergic to Flunisolide. Or if they are allergic to any other medications. Ask the pharmacist to provide a list of the ingredients.

2. Patients should inform their doctor and pharmacist about all medications, vitamins, supplements, and herbal products they are taking or plan to take. This includes oral steroids (like dexamethasone, methylprednisolone, and prednisone) and seizure medications. The doctor may adjust dosages or monitor for side effects. Many drugs can interact with Flunisolide. So it is crucial to disclose all medications, even those not specifically listed.

3. Flunisolide should not be used during an asthma attack. The physician will prescribe a short-acting inhaler for this purpose. Call the physician if the patient has an asthma attack that fails to stop after using the fast-acting asthma medication or if the patient needs to use more of the fast-acting medication than usual.

4. The physician should be informed if the patient has been on bed rest, unable to move around for a longer time, has osteoporosis, tuberculosis, cataracts, or glaucoma, or has any type of untreated infection anywhere in the body, such as a herpes eye infection.

5. The doctor should be notified if the patient is pregnant, intends to become pregnant, or is nursing. If a patient does become pregnant during the use of Flunisolide, the doctor should be contacted.

6. If the patient has surgery, even dental surgery, inform the physician or dentist.

7. Reducing oral steroid doses can worsen existing conditions like asthma, arthritis, or eczema. Inform your doctor if this occurs, or if you experience fatigue, muscle weakness or pain, abdominal or leg pain, appetite or weight loss, nausea, vomiting, diarrhea, dizziness, fainting, depression, irritability, or skin darkening. During this time, your body may struggle with stress from surgery, illness, severe asthma attacks, or injury. Contact your doctor immediately if you become ill. Ensure all healthcare providers know you recently switched from oral steroids to Flunisolide. Carry a medical ID card or bracelet indicating you may need steroid treatment in emergencies.

8. Inform your doctor if you've never had chickenpox or measles, and haven't been vaccinated. Avoid contact with sick individuals, especially those with chickenpox or measles. If exposed or if symptoms develop, contact your doctor immediately. You may need preventive treatment.

9. Flunisolide can sometimes cause immediate wheezing and breathing difficulty after inhalation. If this occurs, use your rescue inhaler and contact your doctor immediately. Do not use Flunisolide again unless instructed by your doctor.

How to Store and Dispose of Flunisolide?

Keep Flunisolide out of reach of children. Children should use it under adult supervision. Use only the provided purple actuator and gray spacer assembly with the Flunisolide canister; do not mix with other products. Do not separate the purple actuator from the gray spacer. Do not use external spacers or holding chambers. Contents are under pressure; do not puncture. Avoid heat, open flame, extreme cold, and direct sunlight. Avoid temperatures above 110°F (47°C). Do not incinerate. Store at room temperature (76°F/24°C), with allowed excursions of 15 to 30°C. For best results, use at room temperature.

What Should Be Done in the Case of Flunisolide Overdose?

Administration of the drug should be discontinued immediately, and the doctor should be called. The patient should be brought to the emergency department in case of severe conditions. In a few studies, clinically adverse effects were not seen.

What Can Be Done if a Dose of Flunisolide Is Missed?

If the Flunisolide dose is missed, it should be cut and the regular dose continued as per the dosing schedule. A double dose shall not be used to compensate for a missed one.

For Doctors

1. Indications: Flunisolide inhalation aerosol is recommended for the long-term management of asthma. It is used in both adults and children aged six and older. Flunisolide works for asthma patients who require oral corticosteroids. In these cases, adding Flunisolide inhalation aerosol may reduce or eliminate the need for oral steroids. However, Flunisolide inhalation aerosol is not used to treat acute bronchospasms. It is also not suitable for children under six years of age.
2. Contraindications: It is not recommended for immediate treatment in the status asthmaticus or other acute asthma episodes where intensive efforts are needed.
3. Precautions:

1. Local Infections: Clinical studies show Flunisolide can cause localized infections, such as Candida albicans or Aspergillus niger. These infections occur in the mouth, throat, and sometimes the larynx. Oral thrush should be treated with antifungal therapy. Flunisolide therapy may need temporary interruption under medical supervision. Rinse the mouth after inhalation.

2. Acute Asthma Episodes: Flunisolide inhalation aerosol is not considered as a bronchodilator. It is not indicated for rapid relief of bronchospasm. During asthmatic episodes, patients may need therapy with systemic corticosteroids.

3. Immunosuppression: Immunosuppressing drugs increase infection risk. For example, chickenpox and measles can be severe, even fatal, in non-immune children. If a patient develops chickenpox, antiviral treatment should be considered. Inhaled corticosteroids should be used cautiously due to the risk of worsening infections.

4. Hypercorticism and Adrenal Suppression: Flunisolide can control asthma symptoms in responsive patients with less HPA axis suppression than oral prednisone. This benefit occurs when recommended dosages are followed and patients are titrated to the lowest effective dose. Individual cortisol production varies, so physicians must consider this when prescribing Flunisolide. If HPA axis suppression occurs, gradually decrease the Flunisolide dose and taper systemic corticosteroids, following standard asthma management procedures.

5. Reduction in Bone Mineral Density: Long-term inhaled corticosteroid use, including Flunisolide, can decrease bone mineral density (BMD). The long-term impact of these small BMD changes is unclear. Patients with risk factors like osteoporosis, prolonged immobility, postmenopausal status, poor nutrition, tobacco use, advanced age, or chronic use of bone-loss medications should be monitored and treated according to established guidelines.

6. Effects on Growth: Inhaled corticosteroids, such as Flunisolide, can decrease growth velocity in pediatric patients. The growth pattern should be monitored in pediatric and teenage patients.

7. Glaucoma and Cataracts: have been defined as a state with increased intraocular pressure, and cataracts are documented in patients under the long-term administration of inhaled corticosteroids, like Flunisolide. Patients should be monitored closely, specifically those who show a vision change or have a record of increased intraocular pressure, glaucoma, or cataracts.

Pharmacodynamics: The dose-finding for Flunisolide inhalation aerosol was based on the comparability of systemic exposure to Flunisolide CFC inhalation aerosol. Two random studies examined the impact of Flunisolide CFC inhalation aerosol and Flunisolide inhalation aerosol on pharmacokinetics and 12-hour plasma cortisol levels.

Chemical TaxonomyGeneric Name: Flunisolide.Chemical Class: Glucocorticoid.Molecular Formula: C24H30F2O6.

Mechanism of Action: Flunisolide has shown significant anti-inflammatory activity in traditional test systems. It is a corticosteroid with much more potential than cortisol in animal anti-inflammatory tests. It is many hundred times more active than dexamethasone in anti-inflammatory actions, as measured by the McKenzie skin blanching test. The clinical relevance of these observations is not known. The exact mechanism of corticosteroid action is not understood. Airway inflammation is a critical element in asthma pathogenesis. The anti-inflammatory effects of corticosteroids may help account for their beneficial effects on asthma.

Pharmacokinetics:

1. Absorption: Flunisolide has been rapidly absorbed. Oral bioavailability is less than 7 percent. Within the dose range of 80 micrograms to 320 micrograms of Flunisolide inhalation aerosol, Cmax values rise proportionately with dose following single and multiple-dose administration.

2. Distribution: Flunisolide is widely distributed throughout the body, with mean apparent volume of distribution values between 170 and 350 liters following a one-time dose of 320 micrograms of Flunisolide aerosol for inhalation.

3. Metabolism: Flunisolide is rapidly and extensively metabolized after a single 320 microgram dose of Flunisolide inhalation aerosol and 0.71 microgram/milliliter after multiple doses of Flunisolide inhalation aerosol.

4. Elimination: When inhaled twice daily, up to 12 days' administration of Flunisolide did not cause an appreciable accumulation of Flunisolide. Twice daily, Flunisolide was inhaled. This was carried out for a maximum of 12 days. There was no appreciable accumulation of Flunisolide. When multiple doses of 160 micrograms and 320 micrograms, Cmax values were 1.0 nanogram per milliliter and 2.1 nanograms per milliliter, respectively. Multiple doses were given. The doses were 160 micrograms and 320 micrograms. The Cmax level for 160 micrograms was 1.0 nanograms per milliliter. The Cmax level for 320 micrograms was 2.1 nanograms per milliliter.

Toxicology: Carcinogenesis, Mutagenesis, Impairment of Fertility:

In one study, Flunisolide oral doses of as much as 500 micrograms per kilogram per day failed to show any carcinogenic effect. In another study, Flunisolide was given by diet. The dose was 2.5 mcg/kg/day. It caused an increased incidence of adenomas of the mammary glands in females and islet cell adenomas of the pancreas in females. The relevance of these findings in humans is unclear.

Drug Interactions to Watch Out for

No interactions are reported with flunisolide and other medications. Be sure to tell your doctor about everything you're taking, not just prescriptions. That means over-the-counter meds, vitamins, minerals, herbal supplements, and anything else you take regularly. It all matters.

Clinical Studies:

Flunisolide has been tested in many studies and has been shown to work well for managing breathing issues.

1. Long-Term Asthma Management: A 52-week study in the Annals of Allergy, Asthma & Immunology evaluated the long-term efficacy of flunisolide in chronic asthma patients. The study followed 438 patients. The study demonstrated significant improvement in pulmonary function, a remarkable reduction in asthma exacerbations, and a 40% reduction in emergency medical treatment. Patients also felt better overall and reported a better quality of life.

2. Pediatric Respiratory Response: Pediatric studies have helped establish flunisolide's efficacy and safety in children. One study was presented in the Journal of Pediatric Pulmonology. The study was on the effects of the drug in children. The children ranged in age from 6 to 18 years. The study proved to have little interference with growth. The study also proved sustained control of respiratory symptoms. These results assure physicians and parents regarding long-term pediatric use of the medication.

3. Comparative Efficacy Research: Comparative studies have ranked flunisolide as a competitive option among inhaled corticosteroids. A meta-analysis in Chest Journal compared several inhaled corticosteroids and pointed out flunisolide's comparable effectiveness in managing asthma symptoms. Flunisolide also had an advantageous side effect profile.

During the Administration of the Drug:

Unless the physician advises otherwise, the normal diet should be continued.

Clinical Pharmacology

Flunisolide represents an advanced approach to respiratory medication management:

Pharmacological Characteristics

1. Highly selective anti-inflammatory corticosteroid.

2. Targets specific inflammatory pathways in respiratory tissues.

3. Precise binding to glucocorticoid receptors.

4. Minimal systemic steroid-related side effects.

Respiratory System Optimization

1. Inhibits inflammatory cell migration.

2. Reduces inflammatory cytokine production.

3. Prevents airway hyperresponsiveness.

4. Minimizes mucus hypersecretion.

Key Performance Metrics

1. Rapid respiratory tract absorption.

2. Peak concentration: 1-2 hours.

3. Short half-life (2-3 hours).

4. Consistent symptom management.

5. Suitable for long-term treatment.

Therapeutic Advantages

1. Personalized respiratory management.

2. Precision inflammatory response control.

3. Minimally invasive treatment strategy.

Key Takeaway/Note from Icliniq

Flunisolide is an inhaled corticosteroid for long-term asthma management, not acute attacks. It decreases airway inflammation in adults and children aged six years and older. Users must be aware of side effects and tell their doctor about all medications.